pamidronate has been researched along with Edema in 4 studies
Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.
Excerpt | Relevance | Reference |
---|---|---|
"Pamidronate (60 mg) was given intravenously on Days 1, 2, 14, 28, and 56, over 4 h in 500 ml of 5% dextrose." | 2.70 | Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. ( Aaron, S; Chiu, P; Jhangri, GS; Lambert, R; Leclercq, S; Maksymowych, WP; Russell, AS; Wong, B, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liao, M | 1 |
Magcalas, P | 1 |
Hopkins-Braddock, P | 1 |
Kraenzlin, ME | 1 |
Graf, C | 1 |
Meier, C | 1 |
Kraenzlin, C | 1 |
Friedrich, NF | 1 |
Lee, R | 1 |
Al-Adhoubi, NK | 1 |
Jawad, AS | 1 |
Maksymowych, WP | 1 |
Lambert, R | 1 |
Jhangri, GS | 1 |
Leclercq, S | 1 |
Chiu, P | 1 |
Wong, B | 1 |
Aaron, S | 1 |
Russell, AS | 1 |
1 trial available for pamidronate and Edema
Article | Year |
---|---|
Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Reactive; Blood Sedimentation; Bone Marrow; C-Reactive P | 2001 |
3 other studies available for pamidronate and Edema
Article | Year |
---|---|
Case 4: How Much Is Too Much? A Case of Hypercalcemia in a 6-year-old Boy.
Topics: Bone Density Conservation Agents; Calcitonin; Child; Diagnosis, Differential; Dietary Supplements; D | 2015 |
Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
Topics: Alendronate; Alkaline Phosphatase; Amino Acids; Bone Density Conservation Agents; Bone Marrow Diseas | 2010 |
Bone marrow oedema of the radius presenting as tennis elbow.
Topics: Adult; Bone Density Conservation Agents; Bone Marrow Diseases; Diphosphonates; Edema; Female; Humans | 2013 |